Informa plc (LON:INF) Receives Consensus Rating of “Moderate Buy” from Analysts

Shares of Informa plc (LON:INF) have received a consensus recommendation of “Moderate Buy” from the six analysts that are currently covering the firm, Marketbeat reports. One investment analyst has rated the stock with a hold recommendation and five have assigned a buy recommendation to the company. The average 1-year price objective among brokerages that have covered the stock in the last year is GBX 1,100.83.

Separately, Citigroup decreased their target price on Informa from GBX 1,000 to GBX 850 and set a “neutral” rating on the stock in a report on Thursday, April 9th.

Insider Buying and Selling

In other news, insider Gareth Wright acquired 222 shares of the firm’s stock in a transaction on Wednesday, May 20th. The shares were purchased at an average cost of GBX 809 per share, with a total value of £1,795.98. Also, insider Stephen A. Carter acquired 222 shares of the firm’s stock in a transaction on Wednesday, May 20th. The stock was purchased at an average cost of GBX 809 per share, for a total transaction of £1,795.98. 0.39% of the stock is currently owned by insiders.

Informa Stock Up 0.3%

INF stock opened at GBX 811.03 on Friday. The company has a current ratio of 0.44, a quick ratio of 1.70 and a debt-to-equity ratio of 61.56. The firm has a market capitalization of £10.23 billion, a PE ratio of 1,013.79, a PEG ratio of 0.75 and a beta of 0.70. Informa has a 1-year low of GBX 719 and a 1-year high of GBX 1,000. The business’s 50 day simple moving average is GBX 788.33 and its 200 day simple moving average is GBX 852.14.

Informa (LON:INF) last posted its earnings results on Thursday, March 12th. The company reported GBX 56 earnings per share for the quarter. Informa had a return on equity of 0.87% and a net margin of 1.64%. As a group, research analysts anticipate that Informa will post 59.3240265 EPS for the current year.

Informa Company Profile

Our events, digital products and academic research services connect specialists with knowledge, helping them learn more, know more and do more.

We do this in dozens of specialist markets and subject matter categories, including in Healthcare & Pharma, Technology, Finance, Education, Marketing, Health & Nutrition, Foodservice, and many more.

And we do this through a range of products and services, including major live events, specialist media and content, expert research articles, books and open research platforms, accredited training, buyer discovery services, and digital demand and lead-generation services.